MTDH and posterior cortical atrophy: Based on the oncogenic function of MTDH and its inhibition by miR-145-5p or miR-145-3p, the miR-145-5p/MTDH and miR-145-3p/MTDH pathways provide potential therapeutic targets for miRNA-based therapy of PCa [58,59].